• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS27
Device Problem Degraded (1153)
Patient Problems Aortic Valve Stenosis (1717); Thrombocytopenia (4431); Heart Failure/Congestive Heart Failure (4446)
Event Date 07/06/2021
Event Type  Injury  
Event Description
The manufacturer was informed of the following event through report (ref.Mw5147012) from fda.On (b)(6) 2017, patient had pre-operative diagnosis: 1- aortic stenosis (severe) 2- lv hypertrophy 3-reduced lv function (ef 50%) 4- renal failure (stage 3) with following operation 1- minimally invasive aortic valve replacement (xl perceval pericardial heart valve) via right anterior mini-thoracotomy 2- rigid titanium plate for third rib fixation.Patient tolerated procedure well.Since patient was diagnosed with severe prostatic aortic valve stenosis, acute on chronic diastolic heart failure, hepatitis c chronic kidney disease stage iii, thrombocytopenia suspected liver cirrhosis, mean aortic gradient of the prostatic valve was 72 mmhg, reintervention (tavr) was performed on 6 july 2021.Mortality score is 14.3% high risk.Operative procedure included urgent transfemoral transcatheter aortic valve replacement with a 26 mm edwards sapient s3 valve, deployment of the s3 valve into the degenerated xl perceval valve central cerebral embolic protection, large sheath 14 french left common femoral artery, pigtail catheter 5 french right common femoral artery, temporary pacemaker access site left common femoral vein, and 6 french sheath per md records.Reportedly, patient tolerated procedure well and was returned to recovery in stable condition.No further information is available at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
MDR Report Key18234449
MDR Text Key329317667
Report Number3019892983-2023-01021
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 10/11/2023,11/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/29/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVS27
Device Catalogue NumberICV1211
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA10/11/2023
Distributor Facility Aware Date10/31/2023
Event Location Hospital
Date Report to Manufacturer10/31/2023
Date Manufacturer Received10/31/2023
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-